Triclosan Disrupts SKN-1/Nrf2-Mediated Oxidative Stress Response in C. elegans and Human Mesenchymal Stem Cells by �씠吏꾩슦
1SCiEntifiC RepORTS | 7: 12592  | DOI:10.1038/s41598-017-12719-3
www.nature.com/scientificreports
Triclosan Disrupts SKN-1/Nrf2-
Mediated Oxidative Stress 
Response in C. elegans and Human 
Mesenchymal Stem Cells
Dong Suk Yoon1,2, Yoorim Choi2,3, Dong Seok Cha1,10, Peng Zhang4,5, Seong Mi Choi2,3, 
Mohammad Abdulmohsen Alfhili1,6, Joseph Ryan Polli7, DeQwon Pendergrass1,7, Faten A. 
Taki7, Brahmam Kapalavavi8, Xiaoping Pan7, Baohong Zhang7, T. Keith Blackwell4,5, Jin Woo 
Lee2,3 & Myon-Hee Lee1,9
Triclosan (TCS), an antimicrobial chemical with potential endocrine-disrupting properties, may pose a 
risk to early embryonic development and cellular homeostasis during adulthood. Here, we show that 
TCS induces toxicity in both the nematode C. elegans and human mesenchymal stem cells (hMSCs) by 
disrupting the SKN-1/Nrf2-mediated oxidative stress response. Specifically, TCS exposure affected C. 
elegans survival and hMSC proliferation in a dose-dependent manner. Cellular analysis showed that 
TCS inhibited the nuclear localization of SKN-1/Nrf2 and the expression of its target genes, which were 
associated with oxidative stress response. Notably, TCS-induced toxicity was significantly reduced 
by either antioxidant treatment or constitutive SKN-1/Nrf2 activation. As Nrf2 is strongly associated 
with aging and chemoresistance, these findings will provide a novel approach to the identification of 
therapeutic targets and disease treatment.
Triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether; TCS) is a broad-spectrum antimicrobial agent that is 
commonly used in personal care products (e.g., antiseptic soaps, toothpastes, fabrics, and plastics) and medical 
devices (e.g., surgical sutures, catheters, and ureteral stents)1–3. Evidence from in vitro and in vivo animal studies 
has linked TCS to numerous human health problems, including allergies, asthma, and eczema in children, as well 
as breast cancer and neurodegenerative diseases in adults, through various modes of action4.
TCS exerts its antimicrobial effect by interfering with enoyl-acyl carrier protein reductase (FabI) activity, 
which is required for fatty acid and biotin biosynthesis. This ultimately leads to the suppression of bacterial 
growth. Also, TCS destabilizes bacterial membrane by inducing K+ leakage5. Importantly, TCS bears a structural 
similarity to the thyroid hormone thyroxine (T4) and to other known endocrine disruptors, including poly-
chlorinated biphenyls, diethylstilbestrol, and bisphenol A6. The aromatic nature and high chlorine content of 
TCS confer resistance to degradation and persistence in the environment4. Similarly, a pharmacokinetic study 
determined that significant levels of TCS were widely detected in human body fluids and in the surrounding envi-
ronment4. Recent studies have also shown that TCS may interfere with thyroid hormone metabolism in humans 
by acting as a potential endocrine-disrupting chemical (EDC)7. TCS was shown to induce thyroid hormone 
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clearance, possibly through the activation of nuclear receptors such as pregnane X receptor (PXR) and constitu-
tive androstane receptor (CAR). Activated receptors eventually lead to hypothyroxinaemia (significant reduction 
in serum thyroxine levels) – a hallmark of overt hypothyroidism4,8,9. Furthermore, TCS was reported to inhibit the 
detoxification of foreign chemicals in the body through the interaction with the same nuclear receptors, inducing 
the expression of hepatic cytochrome P450 2B10 (CYP2b10)10. In vivo studies in mouse models have shown that 
TCS disrupted liver integrity and compromised liver function10. Moreover, mice subjected to TCS were more 
susceptible to chemically induced liver tumors10. Based on these investigations and the potential risk associated 
with TCS exposure, it is currently classified as a category III compound by the FDA1, which has recently banned 
its use in antibacterial soaps. However, the underlying mechanisms by which TCS causes these numerous health 
problems at the molecular and cellular levels remain poorly understood.
Nuclear factor erythroid-2-related factor 2 (Nrf2) is a mammalian, basic leucine zipper transcription factor 
involved in the activation of more than 100 genes responsible for cellular stress response and cytoprotection11. The 
antioxidant response elements (AREs) are regulatory DNA sequences common to Nrf2 downstream target genes. 
Upon induction, Nrf2 dissociates from its cytoplasmic scaffold protein, Keap1, and translocates to the nucleus 
where it activates a plethora of genes governing energy metabolism, reactive oxygen species (ROS) scavenging 
and elimination, anti-inflammatory signalling, and xenobiotic detoxification12–14. SKN-1 (SKiNhead-1) is the C. 
elegans homolog of Nrf2, and both proteins share the conserved function of cellular defense in response to oxida-
tive stress and xenobiotics15,16. We here show that TCS induces toxicity, at least in part, by disrupting the SKN-1/
Nrf2-mediated oxidative stress response. In this study, we used two powerful model systems, the nematode C. ele-
gans and human mesenchymal stem cells (hMSCs). C. elegans has emerged as an attractive model system for the 
functional analysis of various bioactive and natural compounds. hMSCs are currently used in many clinical trials 
and regenerative medicine studies for their multipotency and self-renewal capabilities. Since the mechanism of 
action of TCS in SKN-1/Nrf2-mediated oxidative stress response may be conserved in diverse cellular processes 
during animal development, tissue homeostasis, and disease modelling, our findings represent seminal insights 
on the interaction of TCS with host cells and the role of SKN-1/Nrf2 in xenobiotic stress response.
Results
Long-term TCS treatment perturbs survival of wild-type worms. At certain doses, EDCs can inter-
fere with the endocrine system and result in developmental disorders. We specifically focused on three potential 
EDCs, namely triclosan (TCS), N,N-diethyl-meta-toluamide (DEET), and methylparaben (MP) (Fig. 1a). TCS is 
an antimicrobial compound found in consumer products and medical devices1–3, DEET is a highly effective insect 
repellent and has been widely used for several decades17, and methylparaben is commonly used as a preservative 
in cosmetics and foods18,19. The toxic effects of these potential EDCs were examined using the nematode C. ele-
gans as a model system. To observe the effect of EDCs on the survival of wild-type worms (from early L1 larvae to 
young adults), isolated embryos were placed on NGM plates containing 0.2 mM TCS, 0.2 mM DEET, 0.2 mM MP, 
or 0.2% ethanol (EtOH), which was used as a control, and incubated for 36 hours at 20 °C (Fig. 1b). The survival 
rate was then determined every 12 hours by scoring live and dead worms under a dissecting microscope. While 
the effects of DEET and MP on the survival of wild-type worms were comparable to those of the EtOH control, 
TCS significantly decreased the survival rate of wild-type worms dose-responsively (Fig. 1c,d). Resistant, live 
worms showed pharyngeal pumping, whereas sensitive, dead worms appeared rod-like in shape and slightly une-
ven in texture (Fig. 1e,f). We also scored the survival rates 4 days past the embryo stage. TCS treatment at 0.1 mM 
slightly decreased the survival rate of wild-type worms, whereas no worms survived 0.2 and 0.4 mM exposure 
levels (Fig. 1g). We next examined the ability of long-term TCS treatment to exert developmental defects in 
wild-type worms. Notably, the majority of surviving worms at 0.1 mM TCS reached adult stage and showed nor-
mal fertility (Fig. 1g). This result suggests that 0.1 mM TCS seems to be a potential threshold concentration for 
survival. Next, we investigated the synergistic effect of TCS and either 0.2 mM DEET or 0.2 mM MP combined 
treatment on the survival of wild-type worms. The co-exposure of DEET and MP did not affect the survival rate 
of wild-type worms (Fig. 1h). However, coupled with TCS treatment, MP significantly exacerbated survival in a 
dose-dependent manner (Fig. 1h,i). Taken together, our results suggest that long-term TCS exposure perturbs 
survival of wild-type worms, and that TCS toxicity was aggravated by co-treatment with MP.
Short-term TCS treatment also perturbs survival of wild-type worms. We also tested the 
short-term effect of TCS exposure on the survival rate of wild-type worms. L1 synchronized wild-type worms 
were subjected to TCS and EtOH control in M9 liquid buffer for 1 hour at 20 °C and the survival rates were scored 
(Fig. 1j). Notably, TCS treatment significantly decreased the survival of the wild-type worms in a dose-dependent 
fashion (Fig. 1k; see Supplementary Fig. 1). Estimates of TCS daily intake reveal concentrations of 47, 65, and 
73 ug/kg/day, for men, women, and children, respectively2. Also, levels as high as 2,100 ug/kg lipid weight and 
3790 ug/L were detected in human breast milk20, and urine21, respectively. Although the effective concentration 
of TCS was higher than environmentally relevant levels, in toxicological paradigm, it often requires higher con-
centrations of drugs to achieve bioavailability. Also, C. elegans has an outer cuticle that protects against the influx 
of chemicals into the organism22,23. This renders the nematode more resistant to chemical exposure, necessitat-
ing high testing concentrations. Consistent with this notion, mutations in cuticle proteins (e.g., collagen) cause 
hypersensitivity to EDCs in C. elegans22. Exposure levels in the study were chosen to facilitate the identification of 
molecular mechanisms associated with TCS treatment in a relatively short period of time, as opposed to the low 
concentrations found in the environment which would typically require long, repeated exposure incidents for a 
biological response to ensue.
Next, to assess the inter-stage variation in response to TCS, the survival rate of adult worms was also 
measured. The results showed that TCS decreased the survival of adult worms by a similar magnitude (see 
Supplementary Fig. 2). Remarkably, worms that survived the short-term treatment reached adult stage and were 
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Figure 1. Effects of potential endocrine disrupting chemicals on wild-type worm survival. (a) Chemical 
structures of potential endocrine disrupting chemicals (EDCs): triclosan (TCS), DEET, and methylparaben 
(MP). (b) Strategy for long-term treatment of ECDs on NGM plates. (c and d) Individual effects of EDCs 
on the survival of wild-type worms during the first 36 hours from the embryo stage. (e and f) DIC pictures 
of wild-type worms treated with EtOH control (0 mM TCS) and 0.4 mM TCS. (g) The survival rate of TCS-
treated wild-type worms and the percentage of worms that reached adult stage at 4 days past embryos. A red 
line indicates the potential threshold for the survival of wild-type worms against TCS. (h) The combinational 
effect of EDCs (0.2 mM each) on the survival of wild-type worms over the first 36 hours from the embryo stage. 
(i) Dose-dependent effect of MP on the survival rate of 0.1 mM TCS-treated wild-type worms. (j) Strategy for 
short-term TCS treatment in M9 liquid buffer. (k) The survival rate of synchronized L1 wild-type worms. (l) 
The percentage of wild-type worms that reached adult stage against TCS. (m) The percentage of worms that 
have fertile gonads against TCS. (n) DAPI staining of a worm that survived in 0.4 mM TCS. (o) Survived adult 
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fecund (Fig. 1l–n). We also examined germline development by staining dissected gonads with anti-HIM-3 (mei-
otic cell marker), anti-MSP (Major Sperm Protein, sperm marker), and DAPI (DNA marker). Germline staining 
results indicated that survived worms likely had normal germline proliferation, differentiation, and gametogen-
esis (Fig. 1o). Collectively, these results suggest that (1) TCS dose-dependently perturbs the survival of wild-type 
worms; and (2) even at higher concentration of TCS, some worms survived and reached adult stage without 
obvious developmental defects. Therefore, in light of these findings, we proposed that defense mechanisms in 
survived worms were activated immediately upon TCS exposure (Fig. 1p) to levels sufficient to confer resistance 
and survival (Fig. 1q).
TCS increases the level of intracellular ROS. The potential correlation of TCS with oxidative stress 
was recently described in rat thymocytes24 and Tigriopus japonicus25, but the underlying molecular mechanism 
remains unknown. To assess the degree of oxidative stress caused by TCS exposure, we conducted a time-course 
experiment to measure the level of intracellular ROS using the molecular probe H2DCF-DA in a 96-well 
plate. Interestingly, exposure to 0.2 mM TCS resulted in a significant increase in the level of intracellular ROS 
time-dependently (Fig. 2a). We also examined the effect of MP and DEET on intracellular ROS production. No 
significant ROS formation was detected following 0.2 mM of MP or DEET treatment (Fig. 2b). To determine 
whether TCS-induced mortality was positively correlated with oxidative stress, we examined the effect of TCS on 
survival using a mev-1 (abnormal MEthyl Viologen sensitive-1) mutant, which is sensitive to oxidative stress26,27. 
L1 stage mev-1(kn1) mutants were exposed to 0–0.4 mM TCS for 1 hour at 20 °C and their survival rates were 
determined as described above. Compared to wild-type worms, the survival rate of mev-1(kn1) mutants was 
significantly decreased even at the TCS concentration of 0.1 mM (Fig. 2c). We also compared the levels of ROS in 
mev-1(kn1) mutants by H2DCF-DA staining in the absence or presence of TCS. In congruence with the survival 
rate findings, intracellular ROS levels were significantly increased in the mev-1(kn1) mutants even at the TCS 
concentration of 0.025 mM (Fig. 2d). These results suggest that TCS may affect the survival of C. elegans, at least 
in part, by the induction of oxidative stress.
TCS exposure reduced the lifespan of C. elegans. The disruption of oxidative stress resistance affects 
lifespan28. To determine the influence of TCS on the lifespan of C. elegans, we cultured wild-type L1 worms 
on NGM plates containing low concentrations of TCS (0, 0.01, 0.02, and 0.04 mM) and recorded their survival 
rates daily under a dissecting microscope. TCS decreased the lifespan of wild-type worms in a dose-dependent 
manner (Fig. 2e–h; see Supplementary Table 3). We used the mev-1(kn1) mutants to test whether the observed 
lifespan shortening was related to oxidative stress. Mutations in the mev-1 gene rendered worms hypersensitive 
to oxidative stress, and led to a slightly decreased lifespan29 (Fig. 2e). In spite of this phenotype, TCS treatment 
was still able to further augment this effect (Fig. 2f–h). To measure the percentage reduction in lifespan, the aver-
age lifespan of mev-1(kn1) mutants was divided by that of wild-type worms at each concentration of TCS. Even 
at the low concentration of 0.01 mM, the normalized average lifespan of mev-1(kn1) mutants was significantly 
decreased (Fig. 2i). These results suggest that the TCS-induced decrease in lifespan of wild-type worms involved 
the induction of oxidative stress.
TCS altered the expression of genes associated with oxidative stress response. Chemical com-
pounds can induce physiological effects via stimulation of abnormal gene expression during development30–32. 
To test whether TCS exposure alters the expression of genes associated with oxidative stress response (see 
Supplementary Table 4), we analysed the fold change in the expression of select stress-response genes using 
an Eppendorf Mastercycler® Pro PCR machine. The exposure of approximately 2,000 L1 wild-type worms to 
non-lethal concentrations (0.04 mM and 0.1 mM) of TCS for 2 days at 20 °C led to a significant alteration in gene 
expression (Fig. 3a). A significant upregulation was only observed in two genes (old-1 and sod-3), while six genes 
were significantly downregulated (age-1, akt-1, egl-19, gcs-1, pmp-3, and rbd-1); of these, gcs-1 and pmp-3 were 
profoundly downregulated following an increase in TCS concentration (Fig. 3a). These results suggest that TCS 
may alter the expression of genes that are associated with oxidative stress response and defense mechanisms.
To test whether TCS toxicity relied on gcs-1 and pmp-3, we employed gcs-1(ok436) and pmp-3(ok1087) sin-
gle mutant worms. The gene gcs-1, which encodes for γ-glutamyl-cysteine synthetase (γGCS), synthesizes glu-
tathione (GSH) and plays a crucial role in the detoxification of oxidants and toxins in cells33. The gene pmp-3 
(encoding an ABC transporter) modulates the absorption, metabolism, and cytotoxicity of pharmacological 
agents34. L1 stage wild-type, gcs-1 (ok436), and pmp-3 (ok1087) worms were treated with TCS at concentrations of 
0, 0.1, 0.2, and 0.4 mM for 1 hour at 20 °C and the survival rates were measured as described above. The survival 
rate of wild-type worms was approximately 50% and 15% at 0.2 mM and 0.4 mM TCS, respectively (Fig. 3b), with 
a significant further decrease in the gcs-1(ok436) and pmp-3(ok1087) mutants, even at 0.1 mM TCS (Fig. 3c,d). 
We also compared the levels of intracellular ROS in wild-type, gcs-1(RNAi), and pmp-3(ok1087) worms using the 
molecular probe H2DCF-DA in the absence or presence of TCS. Notably, ROS levels in gcs-1(RNAi) and pmp-
3(ok1087) mutant worms were significantly higher than those in wild-type worms even at the lower concentration 
hermaphrodite germlines were extruded and co-stained with anti-HIM-3 antibody (meiosis marker) anti-
MSP antibody (sperm marker), and DAPI (DNA). (p) A rapid activation of defense mechanism against TCS 
contributes to the survival of wild-type worms and their growth to adult stage without obvious developmental 
defects. (q) The potential threshold for the survival of wild-type worms against TCS. Standard deviation bars 
were calculated from at least three independent experiments. p < 0.05(*); p < 0.01(**); p < 0.001(***); Not 
statistically significant (n.s.).
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Figure 2. Individual and synergistic effects of TCS on the lifespan of worms. (a) 0.2 mM TCS 
exposure significantly increases intracellular ROS level at 30 °C. Intracellular ROS level was measured 
spectrophotometrically at excitation and emission wavelengths of 485 nm and 535 nm, respectively. (b) Fold 
change of ROS levels in chemically treated worms. Synchronized L1 worms were exposed to 0.2% EtOH and 
0.2 mM of TCS, MP, or DEET. Five hours later, intracellular ROS levels were measured as described in materials 
and methods. For average fold change of ROS levels, DCF fluorescence values of TCS, MP, or DEET-treated 
worms were divided by those of EtOH control. (c) The effect of TCS on the survival of mev-1(kn1) mutants. 
The mev-1(kn1) mutants are more sensitive to TCS than wild-type worms. (d) Intracellular ROS levels in mev-
1(RNAi) worms in 0.2% EtOH and 0.025 mM TCS. (e–h) The lifespan of wild-type and mev-1(kn1) mutant 
worms at concentrations of 0, 0.01, 0.02, and 0.04 mM TCS. (i) Normalized average lifespan of wild-type, and 
mev-1(kn1) mutant worms. The graph shows the lifespan reduction of TCS-treated worms compared with 
non-treated worms. See Supplementary Table 3 for the statistical analysis of lifespan. Standard deviation bars 
were calculated from at least three independent experiments. p < 0.05(*); p < 0.01(**); p < 0.001(***); Not 
statistically significant (n.s.).
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Figure 3. TCS inhibits the nuclear localization of SKN-1 and expression of its target genes. (a) Fold change of 
gene expression for protein-coding genes related to aging, oxidative stress, and detoxification. All fold change 
values are relative to a control value of one. Values greater than one are considered as upregulation; values less 
than one are considered as downregulation. Statistical analysis was conducted using ANOVA to determine 
the significance at p < 0.05 (†) and p < 0.01 (*). See Supplementary Table 4 for the description of the 21 tested 
genes online. (b–d) Survival rate of wild-type, gcs-1(ok436), and pmp-3(ok1087) mutant worms that were 
exposed to different concentrations of TCS. Broken dots in c and d indicate the average survival rates of wild-
type worms (see Fig. 1b). (e) Intracellular ROS level in gcs-1(RNAi) and pmp-3(ok1087) mutant worms in 0.2% 
EtOH and 0.05 mM TCS. The levels of DCF fluorescence in gcs-1(RNAi) and pmp-3(ok1087) mutant worms 
were normalized to those in wild-type worms. (f) SKN-1::GFP translational fusion construct that previously 
rescued maternal skn-1 lethality64. Schematic of SKN-1::GFP expression in ASI neurons and intestinal nuclei 
under oxidative stress conditions. (g–j) Larval SKN-1::GFP expression under normal conditions and oxidative 
stress conditions. (g) SKN-1::GFP expression in ASI neurons (arrowheads). (h–j) SKN-1::GFP localization 
in the absence or presence of TCS under oxidative stress conditions. (k) Fraction of nuclear SKN-1::GFP 
localization. (l) Constitutively activated skn-1 gain-of-function (gf) mutants are resistant to TCS exposure. (m) 
Intracellular ROS level in skn-1(gf) worms in 0.2% EtOH and 0.2 mM TCS. The levels of DCF fluorescence in 
skn-1(gf) worms were normalized to those in wild-type worms. (n–p) GCS-1::GFP expression in the absence or 
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(0.025 mM) of TCS (Fig. 3e). These results suggest that TCS may induce oxidative stress by altering the expression 
of genes associated with oxidative stress response.
TCS inhibits SKN-1 nuclear localization. The major oxidative stress response is controlled by the tran-
scription factor SKN-1, a homologue of the mammalian Nrf215. The transcription of gcs-1/γGCS and pmp-3/ABC 
transporter genes is activated by the SKN-1/Nrf2 transcription factor in worms and mice15,35,36. The nuclear local-
ization (activation) of SKN-1 proteins increases the expression of detoxification and antioxidant-related genes, 
which reduce cellular oxidative stress37,38. qRT-PCR analysis revealed that the expression of the skn-1 gene is 
slightly subverted in response to TCS (Fig. 3a). It was therefore tested if TCS could inhibit the nuclear localization 
of SKN-1 protein and the subsequent expression of its target genes. For this purpose, a transgenic line expressing 
a skn-1::gfp transgene was utilized (Fig. 3f). In normal conditions, SKN-1 is present in the nuclei of ASI sensory 
neurons (Fig. 3g), but it translocates to the nucleus in the intestine in response to oxidative stress from various 
sources, including the mitochondrial toxin sodium arsenite (5 mM) (Fig. 3f,h). The transgenic worms were simul-
taneously exposed to 5 mM sodium arsenite and different concentrations (0.1–0.2 mM) of TCS for 30 min. The 
nuclear localization of SKN-1 was subsequently analysed by fluorescence microscopy. Remarkably, the nuclear 
localization of SKN-1::GFP in the intestine was suppressed even at 0.1 mM TCS (Fig. 3i–k), which confirmed 
that TCS inhibited the nuclear localization of SKN-1 and the expression of its target genes (e.g., gcs-1 and pmp-3) 
(Fig. 3a). We next tested whether constitutively activated SKN-1 could increase resistance to TCS-induced tox-
icity. For this purpose, we employed a skn-1(lax120) gain-of-function (gf) mutant (henceforth called skn-1(gf)), 
which has been shown to activate the expression of genes associated with metabolism, adaptation to starvation, 
aging, and survival39. The skn-1(gf) mutant worms were exposed to lethal concentrations (≥0.4 mM) of TCS for 
1 hour and the survival rates were compared with those of wild-type control worms. The skn-1(gf) mutants, in 
comparison to wild-type worms, were more resistant to the lethal concentration of TCS (Fig. 3l) and exhibited 
decreased TCS-induced ROS levels (Fig. 3m). These findings suggest that constitutive SKN-1 activation protects 
worms against TCS-induced toxicity and oxidative stress.
TCS inhibits the expression of SKN-1 target, GCS-1. In C. elegans, oxidative stress induces the expres-
sion of gcs-1, a direct downstream target of SKN-1, in the intestines15. To determine whether TCS inhibits the 
expression of gcs-1 through SKN-1, we used a transgenic worm that expresses a gcs-1 promoter::gfp transgene15. 
L1-staged gcs-1::gfp transgenic worms were exposed to SA (0.2 mM; non-lethal concentration) and TCS (0, 
0.1, and 0.2 mM) for 6 hours at 20 °C. Under normal conditions, GCS-1::GFP was found to be detectable in the 
pharynx, but its expression was very weak in the intestine15. As previously reported15, SA exposure dramatically 
increased GCS-1::GFP expression in the anterior and posterior regions of C. elegans intestine (Fig. 3n,q). Notably, 
TCS exposure decreased the SA-induced GCS-1::GFP expression in the intestine (Fig. 3o–q). GCS-1 synthe-
sizes GSH, which is critical for the detoxification of oxidants and toxins33. Moreover, GSH levels are elevated 
in many types of tumor cells (e.g., human ovarian carcinoma) that show increased resistance to chemother-
apeutic agents40,41. To test whether GSH supplementation could protect worms against TCS-induced toxicity, 
wild-type worms were pre-incubated with different concentrations of GSH (0–0.6 mM) for 1 hour at 20 °C, and 
then exposed to a lethal concentration of TCS (0.4 mM) for an additional 1 hour. Notably, the survival rate was 
increased by GSH supplementation in a dose-dependent manner (Fig. 3r). These findings suggest that TCS 
induces cellular toxicity, at least in part, by disrupting SKN-1/GCS-1-mediated oxidative stress response.
TCS affected hMSC proliferation rate. Next, we used bone marrow-derived human mesenchymal stem 
cells (hMSCs) to explore whether the findings observed in worms were conserved in vertebrates. hMSCs have 
demonstrated great potential in the development of in vitro human assays and new target and drug discovery. 
These stem cells can be readily expanded in vitro and can be isolated from a variety of tissue sources. In particular, 
hMSCs are genetically manipulable to differentiate into adipocytes, chondrocytes, and osteocytes. These features 
allow for a variety of disease-related drug screening efforts directed towards stem cell self-renewal, proliferation, 
and differentiation. Using hMSCs, we first assessed the effect of TCS on the proliferation rate. Early passage 
(EP)-hMSCs were exposed to four different concentrations (0, 0.01, 0.02, and 0.04 mM) of TCS for 7 days and the 
proliferation rates were measured using an EZ-Cytox kit. No difference in the proliferation rate between control 
EP-hMSCs and 0.01 and 0.02 mM TCS-treated EP-hMSCs was observed (Fig. 4a). However, the proliferation rate 
of 0.04 mM TCS-treated EP-hMSCs was dramatically reduced after 2 days (Fig. 4a). These results indicated that 
TCS affected the proliferation rate of hMSCs in a dose-dependent manner.
TCS exposure blocked Nrf2 activation in hMSCs. To determine whether TCS could affect the expres-
sion of Nrf2 mRNAs and proteins in hMSCs, EP-hMSCs were treated with 0, 0.01, 0.02, and 0.04 mM TCS for 
12 hours. The expression levels of Nrf2 mRNAs were normalized to that of 18 s rRNA. The qRT-PCR results 
showed that TCS slightly reduced the expression of Nrf2 mRNA at all doses tested (Fig. 4b). We also examined the 
expression level of Nrf2 protein by western blot using an anti-Nrf2 antibody. TCS exposure only slightly reduced 
presence of TCS under oxidative stress conditions. (q) The percentages of animals in each expression category 
are listed. “Low” refers to worms similar to wild-type worms. “Medium” refers to animals in which GCS-1::GFP 
was apparent at modest levels anteriorly or posteriorly. “High” indicates that GCS-1::GFP was present at high 
levels both anteriorly and posteriorly as well as detectable throughout the intestine. (r) GSH supplementation 
represses TCS-induced mortality. Standard deviation bars were calculated from at least three independent 
experiments. p < 0.05(*); p < 0.01(**); p < 0.001(***); Not statistically significant (n.s.).
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Figure 4. TCS induces cytotoxicity in hMSCs by blocking the nuclear localization of Nrf2 protein. (a) Cell 
proliferation assay; each experiment was performed in triplicate. (b) EtOH or TCS-treated MSCs were collected 
at 24 hours to prepare cell lysates. The levels of Nrf2 mRNA were analysed by qRT-PCR. (c) The levels of total 
Nrf2 and phosphorylated Nrf2 proteins were determined by a western blot analysis. β-Actin was used as the 
loading control. (d) Immunofluorescence was performed to confirm the nuclear and cytosolic localization 
of Nrf2 proteins. DAPI was used to stain cell nuclei, and FITC-conjugated secondary antibody was used to 
visualize Nrf2 protein. The images were obtained using confocal microscopy. (e) Cytosolic and nuclear extracts 
were prepared and fractionated in accordance with the manufacturer’s instructions. The protein levels of total 
Nrf2 and phosphorylated Nrf2 were analysed by western blot in the EtOH and TCS-treated human cells. The 
protein level of LDH (lactate dehydrogenase) was used as a loading control for the cytosolic extracts and the 
protein level of LAMIN-B was used as a loading control for nuclear extracts. (f,g) HO-1 and NQO-1 mRNA 
levels were analysed by qRT-PCR. 18S rRNA was used as a loading control. (h–k) TCS blocks t-BHQ-induced 
Nrf2 nuclear localization and the expression of its target genes. (h) Cell proliferation assay. (i) The levels of 
total Nrf2 and phosphorylated Nrf2 proteins were determined by a western blot analysis. β-Actin was used 
as the loading control. (j,k) HO-1 and NQO-1 mRNA levels were analysed by qRT-PCR. 18S rRNA was used 
as a loading control. Standard deviation bars were calculated from at least three independent experiments. 
p < 0.05(*); p < 0.01(**); p < 0.001(***); Not statistically significant (n.s.).
www.nature.com/scientificreports/
9SCiEntifiC RepORTS | 7: 12592  | DOI:10.1038/s41598-017-12719-3
the protein level of Nrf2, whereas the level of phosphorylated (activated) Nrf2 (pNrf2) proteins was significantly 
decreased by TCS exposure dose-responsively (Fig. 4c). pNrf2 reflects nuclear localization where it activates the 
expression of its target genes. To visualize the nuclear localization of pNrf2 proteins in hMSCs, we performed 
immunocytochemical analysis using an anti-Nrf2 antibody. In agreement with the western blot results, only a 
small amount of nuclear pNrf2 was detected in the TCS-treated hMSCs (Fig. 4d). To compare these phenomena 
quantitatively, the cytosolic and nuclear fractions of each experimental group were prepared and analysed by 
western blotting. The level of nuclear pNrf2 protein was decreased in TCS-treated hMSCs, especially at a dose of 
0.04 mM TCS (Fig. 4e). In contrast, cytosolic levels of pNrf2 proteins increased in TCS-treated hMSCs (Fig. 4e). 
We next examined the mRNA levels of HO-1 (encoding haem oxygenase-1) and NQO-1 (encoding NAD(P)H 
quinone dehydrogenase-1) mRNAs, which are known as downstream target genes of Nrf2, by qRT-PCR. Notably, 
the expression levels of HO-1 and NQO-1 were significantly decreased by TCS treatment (Fig. 4f,g). These results 
suggest that TCS exerted an ability to block the nuclear localization of pNrf2 protein, whereas the levels of the 
cytosolic Nrf2 proteins were unchanged by TCS treatment.
TCS exposure inhibited t-BHQ-mediated Nrf2 activation. Under normal conditions, human Nrf2 
exists in the cytoplasm and is degraded via ubiquitination triggered by binding to Kelch-like ECH-associated 
protein 1 (Keap1)42. However, under oxidative stress, Nrf2 is phosphorylated at Ser40 by protein kinase C43 and 
at multiple sites by MAP kinases44 to translocate to the nucleus by disrupting the complex with Keap1 in the 
cytoplasm45,46. t-BHQ (tert-butylhydroquinone, antioxidant agent) is an activator of Nrf2. t-BHQ promotes Nrf2 
stabilization by preventing binding with Keap147, resulting in a higher hMSC proliferation rate. To test whether 
TCS inhibited t-BHQ-induced hMSC proliferation rate, cells were treated with 0.05% DMSO control, t-BHQ 
(0.01 mM), and a t-BHQ (0.01 mM)/TCS (0.02 mM) mixture for 7 days, and the proliferation rates were deter-
mined. As we previously reported48, t-BHQ (0.01 mM) treatment enhanced the proliferation rate compared with 
the DMSO control (Fig. 4h). However, TCS (0.02 mM) suppressed the t-BHQ-induced proliferation rate after day 
3 (Fig. 4h). Next, to test if TCS inhibited t-BHQ-mediated Nrf2 phosphorylation, we treated hMSCs with either 
t-BHQ (0.01 mM) or t-BHQ (0.01 mM)/TCS (0.02 mM) for 12 hours and measured the expression levels of pNrf2 
and total Nrf2 by western blotting. Intriguingly, t-BHQ markedly increased the level of pNrf2, but 0.02 mM TCS 
decreased the levels of t-BHQ-induced pNrf2 (Fig. 4i). However, no changes in the levels of total Nrf2 proteins 
were observed in t-BHQ alone or t-BHQ/TCS-treated hMSCs (Fig. 4i). Next, we determined whether TCS inhib-
ited the t-BHQ-induced expression of Nrf2 target genes by analysing t-BHQ- and tBHQ/TCS-treated hMSC 
extracts by qRT-PCR. The levels of HO-1 and NQO-1 transcripts were normalized to the level of 18 s rRNA. As 
previously reported49, t-BHQ significantly increased the transcript levels of HO-1 and NQO1 transcripts, but TCS 
efficiently suppressed this increase (Fig. 4j,k). These results suggested that TCS inhibited the nuclear localization 
of pNrf2 and subsequently suppressed the expression of its target genes, which are associated with oxidative 
stress-mediated defense mechanisms.
Discussion
This work demonstrated that TCS induced oxidative stress by the disruption of SKN-1/Nrf2-mediated oxidative 
stress response, in two powerful model systems, C. elegans and hMSCs. Based on our findings, we have sug-
gested a possible action mechanism of TCS in SKN-1/Nrf2-mediated oxidative stress response and detoxification 
(Fig. 5). Under oxidative stress conditions, pSKN-1/pNrf2 proteins translocate from the cytoplasm to the nucleus 
and then protect cells or animals from oxidative stress by the activation of target genes (e.g., gcs-1 and pmp-3), 
which are associated with oxidative stress response and detoxification mechanisms. GCS-1/γGCS plays an impor-
tant role in the detoxification of oxidants and toxins from cells33. The PMP-3/ABC transporter mediates the efflux 
of molecules, including metabolites and toxic agents (e.g., drug, chemicals). However, TCS inhibited the trans-
location of pSKN-1/pNrf2 proteins into the nucleus and thereby suppressed the expression of the gcs-1/γGCS1 
Figure 5. A proposed mechanism of action for TCS in normal and cancer cells. See text for details.
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and pmp-3/ABC transporter genes. Therefore, we suggest that TCS induces oxidative stress and intracellular 
accumulation of toxins, at least in part, through disrupting SKN-1/Nrf2-mediated oxidative stress response and 
detoxification mechanism.
Oxidative stress is defined as an imbalance between the production of reactive oxygen species (ROS) and their 
elimination by protective mechanisms. This imbalance leads to the oxidative damage of biomolecules and cells 
within the body. Oxidative stress intertwine with the multiple stages of the cancer process, including initiation, 
promotion, and progression50–52. Moreover, ROS plays a major role in tumor initiation and survival, as induced by 
a variety of agents in several model systems, including humans. ROS-induced oxidative stress can be reduced by 
the main cellular defense mechanisms53. One of the major regulators is Nrf2, which activates the cellular antiox-
idant response by inducing the transcription of its target genes. Nrf2 target genes protect cells from the effects of 
xenobiotics and oxidative stress54 and inhibit carcinogenesis55. Therefore, although Nrf2 has been generally con-
sidered as a tumor suppressor, it can also protect cancer cells from oxidative stress and chemotherapeutic agents 
(Fig. 5). Recent studies have revealed that Nrf2 pathway activation favoured tumor survival with an increased 
chemoresistance to standard chemotherapy54. Although whether the activation or inhibition of Nrf2 is useful 
for the prevention or treatment of cancer remains a highly controversial issue, identification of Nrf2 inhibitors 
will be of value to the development of cancer therapeutic advances. For instance, brusatol was previously iden-
tified as a chemical inhibitor of the Nrf2 pathway56. Brusatol was able to enhance the efficacy of chemotherapy 
through the inhibition of Nrf2-mediated defense mechanisms56. Mechanistically, brusatol selectively decreased 
Nrf2 protein levels through enhanced ubiquitination and degradation56. Importantly, brusatol sensitized cancer 
cells and xenografts to chemotherapeutic drugs, such as cisplatin, in an Nrf2-dependent manner56. Our studies 
have also identified TCS as a potential chemical inhibitor of the Nrf2 pathway. Although the detailed mechanism 
by which TCS inhibited the nuclear localization of pNrf2 proteins was not addressed in this study, future research 
not only will address this aspect, but will also greatly contribute to our understanding of Nrf2-mediated defense 
mechanisms and chemoresistance.
Various environmental stresses can induce the excessive production of ROS, which triggers cellular senes-
cence and abnormal differentiation in hMSCs57. The results in C. elegans and hMSCs indicated that TCS may 
induce cellular toxicity by the disruption of SKN-1/Nrf2-mediated oxidative stress response. Specifically, TCS 
inhibited the nuclear localization of Nrf2 in EP-hMSCs, and consequently, the expression of its downstream 
target genes (e.g., HO-1 and NQO-1). These results suggest that TCS may promote the senescence of EP-hMSCs. 
It was recently reported that Nrf2 activation by t-BHQ promotes stem cell capacity in late passage (LP)-hMSCs 
through Sirt1 expression48. After stimulation by t-BHQ, Nrf2 proteins are released from Keap1 (Kelch-like 
ECH-Associated Protein 1) and translocate into the nucleus58. t-BHQ treatment in LP-MSCs promotes Nrf2 
phosphorylation, which activates the expression of target genes (HO-1 and NQO1) and Sirt1 by similar levels 
to those observed in EP-hMSCs. Intriguingly, t-BHQ-induced activation of Nrf2 in LP-hMSCs promoted stem 
cell capacity of hMSCs with increased proliferation and differentiation abilities into osteogenic and adipogenic 
lineages. These results suggest that active Nrf2 may mediate Sirt1 to regain stem cell capacity in LP-hMSCs. As 
TCS affected Nrf2 nuclear localization, we proposed that TCS may also affect stem cell capacity during aging. 
Altogether, since Nrf2 pathways are involved in multiple physiological processes during development and in 
cancer cell chemoresistance, our findings provide a paradigm that may facilitate pharmacological approaches to 
therapeutic targeting and disease modelling.
Materials and Methods
Chemicals. Triclosan (5-Chloro-2-(2,4-dichlorophenoxy) phenol, TCS), DEET (N,N-diethyl-meta-
toluamide), and methylparaben (Methyl 4-hydroxybenzoate, MP) as shown in Fig. 1a were purchased from 
Sigma Aldrich (MO, USA). All other solvents and chemicals used in the study were of analytical grade. See 
Supplementary Table 7 for chemical information.
Preparation of chemical stock solution and chemical treatment. TCS, DEET, and MP powders were 
dissolved in ethanol as a solvent. To investigate the toxicity of selected chemicals, all stock solutions (100 mM) 
were diluted to final concentrations of 0.1, 0.2, and 0.4 mM with the sterilized NGM (Nematode Growth Media: 
3 g NaCl, 2.5 g Pepton, 17 g Agar, 1 ml 1 M CaCl2, 1 ml 1 M MgSO4, 25 ml 1 M KPO4 (pH 6.0), 1 ml Cholesterol 
(5 mg/1 ml), H2O to 1 litre) media before plating (see Fig. 1b) or M9 buffer (3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 
1 ml 1 M MgSO4, H2O to 1 litre) (see Fig. 1j). For long-term TCS exposure in NGM plates (see Fig. 1b), isolated 
wild-type embryos were plated on NGM plates containing the selected chemicals for 36 hours at 20 °C. The sur-
vival rate was determined every 12 hours by scoring live and dead worms under a dissecting microscope. For 
short-term TCS exposure in M9 liquid buffer (see Fig. 1j), synchronized L1 stage larvae were incubated in M9 
buffer containing the selected chemicals for 1 hour at 20 °C. Following treatment, worms were washed with fresh 
M9 buffer to remove remaining traces and were transferred to the NGM plates seeded with E. coli OP50. TCS 
solution (0 mM to 0.4 mM) and mixtures of TCS, DEET, and MP (0.2 mM) of each were prepared by adding 
appropriate quantities of solutes to a volumetric flask and filling to the mark with ethanol.
C. elegans strains and culture conditions. Wild-type N2, other mutants and transgenic worms were 
obtained from the Caenorhabditis Genetics Center (CGC) (see Supplementary Table 1). These strains were cul-
tured at 20 °C under standard growth conditions on an NGM agar plates seeded with E. coli. OP50. For toxicology 
studies, the worms were synchronized using a bleaching solution (0.5 M NaOH and 1.2% NaClO). Then, the 
obtained embryos or L1 stage larvae were exposed to the solution consisting of either only TCS or a combination 
of TCS with DEET and MP for 1 hour at 20 °C, and the effects of the chemicals on survival rate, lifespan, and gene 
expression were measured.
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Survival assay. The survival assays were performed using wild-type(N2) and three mev-1(kn1), gcs-1(ok436), 
and pmp-3(ok1087) mutants (see Supplementary Table 1). After 1 hour of chemical exposure, synchronized L1 
stage larvae were washed three times with fresh M9 buffer and transferred to the NGM plates with E. coli OP50. 
Their viability was measured immediately or every 12 hour under a dissecting microscope. Test worms were 
considered dead when they failed to respond to prodding with the tip of a platinum wire. Standard deviation bars 
were calculated from at least three independent experiments.
Lifespan assay. The lifespan assays were performed using wild-type(N2) and mev-1(kn1) mutants. 
Synchronized L1 stage larvae were transferred to the NGM plate in the absence or presence of TCS (0.02 mM 
and 0.04 mM). The worms were transferred to fresh NGM plate every 2 days and dead worms were counted daily. 
Standard deviation bars were calculated from three independent experiments.
Measurement of intracellular ROS (Reactive Oxygen Species). Intracellular ROS in the worms was 
measured using molecular probe 2′,7′-dichlorodihydrofluoroscein diacetate (H2DCF-DA). Wild-type(N2) or 
mutant worms were exposed to either EtOH or TCS for the measurement of intracellular ROS. Chemical-treated 
L1-arrested larvae were then transferred into the 96-well plate containing 50 μL of M9 buffer. Immediately 50 μL 
of 50 μM H2DCF-DA was added to each well. The basal fluorescence was quantified using a microplate fluores-
cence reader at an excitation wavelength of 485 nm and an emission wavelength of 535 nm. Plates were read every 
30 minutes for 5 hours. Three replicate experiments were conducted.
Gene expression analysis. After the exposure of L1 stage larva to 0.02 mM and 0.04 mM of TCS, about 
2,000 L1 stage larvae were transferred to fresh NGM plates seeded with E.coli OP50. These worms were then 
incubated for 2 days at 20 °C before they were harvested in 1.5 ml microtube. Total RNA was extracted from the 
worms using mirVanaTM miRNA Isolation Kit (Life Technologies). Quality and purity of total RNA was quanti-
fied by a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE, USA). For reverse transcription (RT), 
650 ng of total RNA from control and each treatment sample were used. RNA was transcribed to single-stranded 
cDNA using the reverse primer Poly(dT). RT-PCR was conducted in 250 μL microcentrifuge tubes and reacted 
in a 15 μL solution. This solution consists of precalculated amounts of DNase/RNase-free water, 1,000 ng of total 
RNA, 0.19 μL RNase inhibitor (20 U/μL), 0.15 μL 100 mM dNTPs, 10× RT buffer, 1 μL MultiScribeTM reverse 
transcriptase (50 U/μL), and 2 μL of Poly(dT) primer mix. The reactions were performed using an Eppendorf 
Mastercycler® Pro PCR machine. Quantitative real-time PCR (qRT-PCR) reactions were performed in 10 μL 
solutions, consisting of 2 μL DNase/RNase free water, 5 μL SYBR green PCR master mix, 1 μL RT PCR product 
(diluted with 85 μL of DNase/RNase free water), and 2 μL of primer mix. The reactions were performed with 
a VIIATM 7 Real-Time PCR system using programmed temperature. The programmed temperature evaluation 
starts with an initial polymerase activation stage for 10 minutes at 95 °C, followed by denaturation for 15 seconds 
at 95 °C, and an annealing/extension step for 60 seconds at 60 °C. The latter two steps were repeated for 40 cycles. 
Four biological replicates were performed per treatment group with each having three technical replicates. In 
qRT-PCR, the expression was normalized to tba-1, which encodes α-tubulin, and 18S rRNA59–61.
GSH rescue assay. Wild-type L1 worms were pretreated with GSH (0–0.6 mM) in M9 buffer for 1 hour and 
then were treated with 0.4 mM TCS for additional 1 hour. Worms were washed three times with M9 buffer and 
then transferred to NGM agar plates. Their viability was measured under a dissecting microscope. Standard devi-
ation bars were calculated from at least three independent experiments.
SKN-1::GFP expression analysis. To analyze the effect of TCS on the localization of SKN-1::GFP in 
response to oxidative stress, skn-1::gfp transgenic worms were exposed to 5 mM sodium arsenite for 30 minutes at 
20 °C in the absence or the presence of TCS (0.1–1 mM), then covered with a glass slip and examined by fluores-
cence microscopy. These worms were scored for the presence of SKN-1::GFP in intestinal nuclei 5 minutes later 
under a fluorescence microscope.
gcs-1::gfp expressional analysis. To analyze the induction of GCS-1::GFP expression in the absence or 
presence of TCS under oxidative stress condition, LD1171 (ldIs3 [gcs-1p::GFP + rol-6(su1006)]) worms were 
exposed to 0.2 mM sodium arsenite for 6 hours at 20 °C in the absence or presence of TCS (0–0.2 mM). The GCS-
1::GFP expression levels were examined under a fluorescence microscope.
Mesenchymal stem cell (MSC) preparation and cultivation. Methods for MSC isolation and cultiva-
tion were previously described62. In brief, bone marrow aspirates were collected from the posterior iliac crests of 
three adult donors, with approval from the Institutional Review Board of Yonsei University College of Medicine. 
The cells were cultured according to previously published protocols48, and their characteristics were confirmed 
using flow cytometry63. MSCs at passage 1 to passage 3 were mainly used in this experiment. TCS was dissolved in 
ethanol, which also served as a control, to prepare testing solutions of 0.01 mM, 0.02 mM, and 0.04 mM.
Cytotoxicity assay (Ez-Cytox). Cell cytotoxicity for TCS was examined using an EZ-Cytox Kit (Daeil 
Lab Service, Seoul, Korea). TCS-treated MSCs were seeded in 12-well cell culture plates 1 × 104 cells per well. 
TCS-treated MSCs were maintained in growth media for 7 days, and the growth media were changed every 2 
days. In brief, the cells were washed by phosphate-buffered saline (PBS), and then 1 mL growth media containing 
20 μl of EZ-Cytox (tetrazolium salts) solution was added to each well and incubated at 37 °C for 3 hours. Then, 
the conditioned media were transferred into 96-well plates, and the absorbance was measured at 450 nm using 
spectrophotometry. All sample were tested in triplicate (n = 3).
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Quantitative real-time polymerase-chain reaction (qPCR). RNA was isolated using an RNeasy kit 
(Qiagen, Valencia, CA, USA). The isolated RNAs were then reverse-transcribed using an Omniscript kit (Qiagen). 
Primer sets were validated and purchased from Bioneer (Daejeon, South Korea; http://www.bioneer.co.kr/). The 
primers used were as follows: Nrf2 [P164742], HO-1 [P133045], and NQO-1 [P113225]. 18S rRNA was used as 
an internal control and the sequence was as follows: 5′-acacggacaggattgacagattg-3′ (sense, NR_003286.2) and 
5′-gccagagtctcgttcgttatcg-3′ (antisense). Mean cycle threshold values from triplicate (n = 3) measurements were 
used to calculate gene expression, with normalization to 18S rRNA levels.
Cytosol and nucleus extraction. Ethanol or TCS-treated MSCs were collected by trypsinization, and 
then nuclear and cytosolic fractionation was conducted using the NE-PER Nuclear and Cytoplasmic Extraction 
Reagents Kit (Thermo Fisher Scientific, Rockford, IL, USA) according to the manufacturer’s instructions. The 
nuclear and cytosolic proteins were analyzed by western blot analysis.
Western blot. Ethanol- or TCS-treated hMSCs were lysed in passive lysis buffer (Promega, Madison, WI, 
USA) after 12 hours of TCS treatment. The Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA) 
were used to determine protein concentrations, and 10 μg of proteins were analyzed by electrophoresis on a 10% 
sodium dodecyl sulfate-polyacrylamide gel (Sigma). 5% skim milk (BD, Sparks, MD, USA) was used to block 
the transferred membranes, and the membranes were incubated for overnight with antibodies against Nrf2 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), phosphorylated-Nrf2 (Abcam, Cambridge, UK), LAMIN-B 
(Santa Cruz Biotechnology), and LDH (Santa Cruz Biotechnology). The membranes were further probed with an 
antibody against β-ACTIN (Santa Cruz Biotechnology), which served as a loading control. See Supplementary 
Table 2 for the information of antibodies, used for this study.
Immunocytochemistry. Ethanol- or TCS-treated hMSCs were seeded at 2,000 cells per square centim-
eter on four-well glass chamber slides (Nalge Nunc International, Rochester, NY, USA), and the cells were 
incubated in a 5% CO2 incubator at 37 °C. The cells were fixed with 4% paraformaldehyde (Sigma) for 30 min-
utes, and then permeabilized with 1% Triton X-100 for 10 minutes followed by blocking for 1 hour with 5% 
bovine serum albumin (BSA) in PBS. The cells were incubated with 1:100 dilution of antibodies against Nrf2 
(Santa Cruz Biotechnology) for 4 hours at room temperature, and then incubated fluorescein isothiocyanate 
(FITC)-conjugated secondary antibodies (Santa Cruz Biotechnology) at a 1:5,000 dilution in 1% BSA-containing 
PBS for 1 hour at room temperature in the dark. The nuclei were stained with 4,6-diamidino-2-phenyindole 
(DAPI) (Sigma) and then examined using a Zeiss LSM700 scanning laser confocal microscope (Zen 2011; Carl 
Zeiss MicroImaging GHBH, Jena,Germany).
Data analysis. The data from the survival rate analysis and lifespan assay were plotted using Microsoft Excel 
software and statistical significance was analyzed by log-rank test. Other data were presented as mean ± standard 
deviation or standard error of the mean depends on the experiments as indicated. Statistical significance of differ-
ences between the control and treated groups were analyzed by one-way analysis of variance (ANOVA). The error 
bars reflect respective standard deviation values.
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